India - English - Central Drugs Standard Control Organization

bombay t. - carbonyl iron,vit.b12,vit.c,folic acid,zinc sulph.,vit.e,selenium - cap - 100mg,15mcg,75mg,22.6mg,15iu.,60mcg - 10

India - English - Central Drugs Standard Control Organization

armour rem. - carbonyl iron,vit.b12,vit.e,folic acid,zinc sulph.,selenium - syr - 60mg,5mcg,15mg,1mg,11mg(zinc gluconate),60mcg - 200ml

India - English - Central Drugs Standard Control Organization

wockhardt - carbonyl iron,vit.b6,vit.b12,folic acid,zinc sulph.,copper,selenium,manganese,iodine - cap - 50mg,3mg,15mcg,1.5mg,20mg,2.5mg,65mcg,2.5mg,150mcg - 30

India - English - Central Drugs Standard Control Organization

sayona - carbonyl iron,vit.b12,vit.e,folic acid,zinc sulph.,selenium - sr cap - 100mg,5mcg,15iu.,1000mcg,61.8mg,60mcg - 10

India - English - Central Drugs Standard Control Organization

gynob ph. - carbonyl iron,vit.b12,vit.e,folic acid,zinc sulph.,selenium - cap - 100mg,5mcg,15mg,100mcg,43mg,65mcg - 10

United States - English - NLM (National Library of Medicine)

trigen laboratories, inc. - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - folic acid 1 mg - taron tm bc is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. taron tm -bc may be used in conjunction with a physician prescribed regimen to help minimize pregnancy related nausea and vomiting. this product is contraindicated in patients with known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm297 - vitamin a 3080 [iu] - to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non lactating mother. it is also useful for improving nutritional status prior to conception

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boc limited - carbonyl sulfide - unknown - carbonyl sulfide mineral-sulfur active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - iron as iron carbonyl and ferric pyrophosphate; vitamin b2 = riboflavin; vitamin b1 nitrate = thiamine nitrate; cobaltous sulfate heptahydrate; glycine; lysine hydrochloride; methionine-dl; copper carbonate; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b6 hydrochloride = pyridoxine hydrochloride; vitamin m = folic acid = pga - oral granules, pellets - iron as iron carbonyl and ferric pyrophosphate mineral-iron active 230.0 mg/30g; vitamin b2 = riboflavin vitamin-b2 active 25.0 mg/30g; vitamin b1 nitrate = thiamine nitrate vitamin-b1 active 15.0 mg/30g; cobaltous sulfate heptahydrate mineral-cobalt other 1.0 mg/30g; glycine amino acid-glycine other 100.0 mg/30g; lysine hydrochloride amino acid-lysine other 200.0 mg/30g; methionine-dl amino acid-methionine-dl other 100.0 mg/30g; copper carbonate mineral-copper-salt other 18.0 mg/30g; vitamin b12 = cyanocobalamin vitamin-b12 other 500.0 mg/30g; vitamin b3 = nicotinamide vitamin-b3 other 300.0 mg/30g; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 other 15.0 mg/30g; vitamin m = folic acid = pga vitamin-m other 7.5 mg/30g - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - iron deficiency | mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | anaemia | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - fenofibric acid (unii: bgf9mn2hu1) (fenofibric acid - unii:bgf9mn2hu1) - fenofibric acid 45 mg - fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet to reduce triglycerides (tg) in patients with severe hypertriglyceridemia. improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacological intervention. markedly elevated levels of serum triglycerides (e.g., > 2,000 mg/dl) may increase the risk of developing pancreatitis. the effect of fenofibric acid delayed-release capsules therapy on reducing this risk has not been adequately studied. fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (ldl-c), total cholesterol (total-c), triglycerides (tg), and apolipoprotein b (apo b), and to increase high-density lipoprotein cholesterol (hdl-c) in patients with primary hypercholesterolemia or mixed dyslipidemia. fenofibrate at a dose equivalent to 135 mg of fenofibric acid delayed-release capsules did not reduce coronary heart disease